These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 26131002

  • 1. Efficacy of Thiopurines in Biologic-Naive Japanese Patients With Crohn's Disease: A Single-Center Experience.
    Yoshino T, Matsuura M, Minami N, Yamada S, Honzawa Y, Kimura M, Koshikawa Y, Madian A, Toyonaga T, Nakase H.
    Intest Res; 2015 Jul; 13(3):266-73. PubMed ID: 26131002
    [Abstract] [Full Text] [Related]

  • 2. Differences in the risk of clinical failure between thiopurine and methotrexate in bio-naïve patients with Crohn's disease: a Korean nationwide population-based study.
    Jun YK, Ji E, Yang HR, Choi Y, Shin CM, Park YS, Kim N, Lee DH, Yoon H.
    Therap Adv Gastroenterol; 2024 Jul; 17():17562848241248321. PubMed ID: 38741927
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Methotrexate for maintaining remission in paediatric Crohn's patients with prior failure or intolerance to thiopurines: a multicenter cohort study.
    Haisma SM, Lijftogt T, Kindermann A, Damen G, de Ridder L, Escher JC, Mearin ML, de Meij T, Hendriks D, George E, Hummel T, Norbruis O, van Rheenen P.
    J Crohns Colitis; 2015 Apr; 9(4):305-11. PubMed ID: 25656249
    [Abstract] [Full Text] [Related]

  • 5. Timing of Thiopurine or Anti-TNF Initiation Is Associated with the Risk of Major Abdominal Surgery in Crohn's Disease: A Retrospective Cohort Study.
    González-Lama Y, Suárez C, González-Partida I, Calvo M, Matallana V, de la Revilla J, Magaz M, Bernardo C, Agudo B, Ibarrola P, Relea L, Arévalo J, Vera MI, Abreu L.
    J Crohns Colitis; 2016 Jan; 10(1):55-60. PubMed ID: 26520164
    [Abstract] [Full Text] [Related]

  • 6. Immunomodulators are associated with a lower risk of first surgery among patients with non-penetrating non-stricturing Crohn's disease.
    Picco MF, Zubiaurre I, Adluni M, Cangemi JR, Shelton D.
    Am J Gastroenterol; 2009 Nov; 104(11):2754-9. PubMed ID: 19584832
    [Abstract] [Full Text] [Related]

  • 7. Thiopurines and Methotrexate Use in IBD Patients in a Biologic Era.
    Mantzaris GJ.
    Curr Treat Options Gastroenterol; 2017 Mar; 15(1):84-104. PubMed ID: 28160250
    [Abstract] [Full Text] [Related]

  • 8. Outcome of medical treatment of stricturing and penetrating Crohn's disease: a retrospective study.
    Samimi R, Flasar MH, Kavic S, Tracy K, Cross RK.
    Inflamm Bowel Dis; 2010 Jul; 16(7):1187-94. PubMed ID: 19902541
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Long-term therapeutic effectiveness of maintenance enteral nutrition for Crohn's disease.
    Konno M, Takahashi M, Toita N, Fujiwara S, Nojima M.
    Pediatr Int; 2015 Apr; 57(2):276-80. PubMed ID: 25203356
    [Abstract] [Full Text] [Related]

  • 11. Tolerance and efficacy of azathioprine in pediatric Crohn's disease.
    Riello L, Talbotec C, Garnier-Lengliné H, Pigneur B, Svahn J, Canioni D, Goulet O, Schmitz J, Ruemmele FM.
    Inflamm Bowel Dis; 2011 Oct; 17(10):2138-43. PubMed ID: 21910176
    [Abstract] [Full Text] [Related]

  • 12. Phenotypic features of Crohn's disease associated with failure of medical treatment.
    Moran GW, Dubeau MF, Kaplan GG, Yang H, Seow CH, Fedorak RN, Dieleman LA, Barkema HW, Ghosh S, Panaccione R, Alberta Inflammatory Bowel Disease Consortium.
    Clin Gastroenterol Hepatol; 2014 Mar; 12(3):434-42.e1. PubMed ID: 23978351
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and Safety of Long-Term Thiopurine Maintenance Treatment in Japanese Patients With Ulcerative Colitis.
    Yamada S, Yoshino T, Matsuura M, Kimura M, Koshikawa Y, Minami N, Toyonaga T, Honzawa Y, Nakase H.
    Intest Res; 2015 Jul; 13(3):250-8. PubMed ID: 26131000
    [Abstract] [Full Text] [Related]

  • 14. Real-World Long-Term Remission Maintenance for 10 Years With Thiopurines in Ulcerative Colitis.
    Matsumoto S, Mashima H.
    Crohns Colitis 360; 2021 Jan; 3(1):otab003. PubMed ID: 36777065
    [Abstract] [Full Text] [Related]

  • 15. Long-Term Prognosis of Japanese Patients with Crohn's Disease Treated by Switching Anti-Tumor Necrosis Factor-α Antibodies.
    Moroi R, Shiga H, Endo K, Yamamoto K, Kuroha M, Kanazawa Y, Kakuta Y, Kinouchi Y, Masamune A.
    Inflamm Intest Dis; 2020 Feb; 5(1):11-19. PubMed ID: 32232050
    [Abstract] [Full Text] [Related]

  • 16. Tacrolimus therapy as an alternative to thiopurines for maintaining remission in patients with refractory ulcerative colitis.
    Yamamoto S, Nakase H, Matsuura M, Masuda S, Inui K, Chiba T.
    J Clin Gastroenterol; 2011 Jul; 45(6):526-30. PubMed ID: 21336140
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Single-incision laparoscopic surgery for stricturing and penetrating Crohn's disease.
    Mizushima T, Nakajima K, Takeyama H, Naito A, Osawa H, Uemura M, Nishimura J, Hata T, Takemasa I, Yamamoto H, Doki Y, Mori M.
    Surg Today; 2016 Feb; 46(2):203-8. PubMed ID: 25735739
    [Abstract] [Full Text] [Related]

  • 19. Prospective Evaluation of the Achievement of Mucosal Healing with Anti-TNF-α Therapy in a Paediatric Crohn's Disease Cohort.
    Nuti F, Civitelli F, Bloise S, Oliva S, Aloi M, Latorre G, Viola F, Cucchiara S.
    J Crohns Colitis; 2016 Jan; 10(1):5-12. PubMed ID: 26188350
    [Abstract] [Full Text] [Related]

  • 20. Long-term prognosis of Japanese patients with biologic-naïve Crohn's disease treated with anti-tumor necrosis factor-α antibodies.
    Moroi R, Endo K, Yamamoto K, Naito T, Onodera M, Kuroha M, Kanazawa Y, Kimura T, Kakuta Y, Masamune A, Kinouchi Y, Shimosegawa T.
    Intest Res; 2019 Jan; 17(1):94-106. PubMed ID: 30508475
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.